Your browser doesn't support javascript.
loading
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS.
Hsu, Denise C; Faldetta, Kimberly F; Pei, Luxin; Sheikh, Virginia; Utay, Netanya S; Roby, Gregg; Rupert, Adam; Fauci, Anthony S; Sereti, Irini.
Afiliação
  • Hsu DC; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Faldetta KF; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Pei L; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Sheikh V; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Utay NS; Department of Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, Galveston.
  • Roby G; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Rupert A; Leidos Biomedical Research, Inc, Frederick, Maryland.
  • Fauci AS; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
  • Sereti I; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
Clin Infect Dis ; 62(2): 258-261, 2016 Jan 15.
Article em En | MEDLINE | ID: mdl-26394669
The management of corticosteroid refractory immune reconstitution inflammatory syndrome (IRIS) is currently unclear. Infliximab administration was associated with clinical improvement without significant adverse events in 3 patients with mycobacterial IRIS. Immunologic and virologic responses to antiretroviral therapy were unaffected. Tumor necrosis factor blockade may be beneficial for IRIS and warrants further study in clinical trials.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Síndrome Inflamatória da Reconstituição Imune / Infliximab / Fatores Imunológicos Limite: Adult / Humans / Male Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Síndrome Inflamatória da Reconstituição Imune / Infliximab / Fatores Imunológicos Limite: Adult / Humans / Male Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article